Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Undecylenic acid is an antifungal used to treat tinea species infections. Undecylenate, or undecylenic acid, is an unsaturated fatty acid with a terminal double bond that is derived from castor oil.
- Mechanism
- Curator reviewed · 5 references
Undecylenic acid demonstrated effectiveness against Candida albicans, which is an opportunistic pathogenic yeast with two cellular morphologies: the round yeast form and the filamentous form with elongated hyphae. Hyphae formation is associated with active infections and virulence. A study proposed that undecylenic acid inhibits biofilm formation of Candida albicans with optimal concentration above 3 mM and disrupts hyphal growth, which is the morphological transition from yeast to filamentous phase, at concentration above 4 mM. Under the drug treatment, hyphal formation related genes, like HWP1, were significantly reduced in transcriptional level leading to poor biofilm formation. Both biofilm and hyphae formation are critical virulence factors for the initiation of skin infection and late development of disseminated infection. Undecylenic acid may also inhibit enzyme involved in lipid metabolism and abolish germ tube formation by carrying protons across the plasma membrane, thus altering cytoplasmic pH.
- Primary indication
- Indicated for the treatment of fungal infections as a salt form.Curator reviewed · 2 structured indications
- Formula / weight
- C11H20O2 · 184.2753 g/mol (avg)
- First approval
- Canada, 1963
- Also known as
- 10-undecenoic acid · Undecenoic acid · Undecylenate
- Code names
- Fema no. 3247
- Brand names
- Fungi-nail
- Fungi-nail Toe and Foot
- Fungicure Maximum Strength
- Sanafitil Antifungal
- Terpenicol
- Tineacide Antifungal
- Ting
Resolves to
FRPZMMHWLSIFAZ-UHFFFAOYSA-NSMILESOC(=O)CCCCCCCCC=CWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Undecylenic acid, and which of those have an active Phase 3 trial?